Stock Alert: Dabur India, Nykaa, Apollo Hospitals Ent, Lenskart Solutions

Kaynes Technology India and Steel Authority of India (SAIL) are barred from F&O Trading on 5 November2025.

Results Today:

Bharti Airtel, Bharat Forge, Bharti Hexacom, Glenmark Pharmaceuticals, Fortis Healthcare, Abbott India, Berger Paints India, Astral, Godfrey Phillips India, Aadhar Housing Finance, Emami, BEML, CESC, AstraZeneca Pharma India, Bikaji Foods International, Blue Jet Healthcare, Healthcare Global Enterprises, Happy Forgings, Go Digit General Insurance, Cello World, Hindustan Construction Company,

Stocks to Watch:

Dabur India reported a 12% YoY increase in net profit to Rs 506 crore in Q2 FY27, compared with Rs 453 crore a year ago, marking its fourth consecutive quarter of double-digit profit growth. Revenue also rose 11.7% to Rs 3,563 crore in Q2 FY27 from Rs 3,191 crore.

Lenskart Solutions reported a 124.70% surge in consolidated net profit to Rs 227.08 crore in Q2 FY27 compared with Rs 102.22 crore in Q2 FY26. Net sales jumped 35.73% YoY to Rs 2845.03 crore in the quarter ended 30th June 2026.

FSN E- Commerce (Nykaa) zoomed 187.62% to Rs 187.62 crore in Q2 FY27 compared with Rs 100.81 crore in Q2 FY26. Net sales climbed 28.14% YoY to Rs 3,006.04 crore in Q2 FY27.

Cupid announced that it has entered into long-term exclusive retail arrangement with V2 Retail. Under this strategic arrangement, Cupid will receive 400 square feet of dedicated and exclusive retail space across V2 Retail?s entire network of over 425 stores, as well as all future stores opened by V2 Retail across India. Management expects the V2 Retail partnership to generate approximately Rs 400 crore in revenue within the next 12 months.

Balkrishna Industries reported 7.11% rise in consolidated net profit to Rs 292.62 crore in Q2 FY27 compared with Rs 273.19 crore in Q2 FY26. Net sales jumped 45.05% YoY to Rs 3471.74 crore in the quarter ended 30th September 2026.

Aurobindo Pharma reported a 32.72% jump in consolidated net profit to Rs 1,126.08 crore in Q2 FY27 compared with Rs 848.45 crore in Q2 FY26. Net sales jumped 24.16% YoY to Rs 10,227.28 crore in the quarter ended 30th September 2026.

Apollo Hospitals Enterprise reported a 33.6% YoY increase in consolidated net profit to Rs 660 crore in Q2, compared with Rs 494 crore in the corresponding quarter last year. Revenue grew 23% to Rs 7,615 crore from Rs 6,189 crore, while EBITDA rose 28.8% to Rs 1,191 crore from Rs 925 crore.

Powered by Capital Market - Live News